Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
3,203,885
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
2,628,004
-
Shares change
-
-144,545
-
Total reported value, excl. options
-
$247,165,094
-
Value change
-
-$14,110,945
-
Number of buys
-
33
-
Number of sells
-
-49
-
Price
-
$94.05
Significant Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) as of Q1 2020
100 filings reported holding UTMD - UTAH MEDICAL PRODUCTS INC - Common Shares as of Q1 2020.
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,628,004 shares
of 3,203,885 outstanding shares and own 82% of the company stock.
Largest 10 shareholders include FMR LLC (433,556 shares), PRICE T ROWE ASSOCIATES INC /MD/ (298,622 shares), RENAISSANCE TECHNOLOGIES LLC (231,514 shares), BlackRock Inc. (224,111 shares), VANGUARD GROUP INC (173,514 shares), DIMENSIONAL FUND ADVISORS LP (170,355 shares), Russell Investments Group, Ltd. (136,972 shares), ProShare Advisors LLC (123,764 shares), STATE STREET CORP (75,779 shares), and RICE HALL JAMES & ASSOCIATES, LLC (71,614 shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.